Dialysis
Genzyme Announces Publication of DCOR Study in Kidney International
August 29, 2007 -- Genzyme Corporation today announced that results from the Dialysis Clinical Outcomes Revisited (DCOR) trial, the largest outcomes study ever conducted in the hemodialysis population, have been published in Kidney International. The three-year trial involving more than 2,100 patients compared the difference in outcomes for patients receiving Renagel® (sevelamer hydrochloride) with those using calcium-based phosphate binders. » read more »
Latest stories
- Iowans Should Take a Holiday from Disaster-Related Stress This Weekend
- EPA Is Not Currently Performing Indoor Air Sampling in Response to Iowa Floods
- EPA Monitors Air Quality in Cleanup from Iowa Floods
- Be Vigilant for Disaster Scam Artists
- Pfizer Announce Changes to Its Funding of Continuing Medical Education in the U.S.
- IBM Acquires Platform Solutions Technology Company
- CoverGirl, P.F. Chang's China Bistro Team up in Celebration of the Essence Music Festival
- AT&T, Cell Phones for Soldiers Surpass First-Year Goal
- Wal-Mart Commits to America's Farmers as Store Produce Aisles Go Local
- IBM, ETH Scientists Advance Supercomputing Simulations to Improve Diagnosis of Osteoporosis
Yes We Can
Yes We Can:




